Ardent Health (NYSE:ARDT) Price Target Raised to $13.00

Ardent Health (NYSE:ARDT) had its price objective upped by Truist Financial from $12.00 to $13.00 in a report published on Thursday morning,Benzinga reports. They currently have a buy rating on the stock.

A number of other brokerages have also issued reports on ARDT. Wall Street Zen lowered shares of Ardent Health from a “buy” rating to a “hold” rating in a research note on Sunday, July 12th. UBS Group increased their price objective on shares of Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a research note on Thursday, May 7th. Guggenheim raised their price objective on shares of Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Thursday. The Goldman Sachs Group reissued a “neutral” rating and issued a $13.00 target price on shares of Ardent Health in a research report on Thursday. Finally, Royal Bank Of Canada cut their target price on shares of Ardent Health from $13.00 to $12.00 and set an “outperform” rating on the stock in a research note on Thursday, July 9th. Seven research analysts have rated the stock with a Buy rating, four have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $12.95.

Ardent Health Price Performance

Shares of NYSE ARDT opened at $11.57 on Thursday. Ardent Health has a fifty-two week low of $7.71 and a fifty-two week high of $15.48. The business has a 50 day moving average price of $9.98 and a two-hundred day moving average price of $9.50. The company has a quick ratio of 2.00, a current ratio of 2.12 and a debt-to-equity ratio of 0.62. The firm has a market cap of $1.66 billion, a PE ratio of 21.04, a price-to-earnings-growth ratio of 3.32 and a beta of 0.70.

Ardent Health (NYSE:ARDT) last announced its earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). The business had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.45%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Sell-side analysts expect that Ardent Health will post 0.95 earnings per share for the current fiscal year.

Insider Activity at Ardent Health

In related news, CFO Alfred Lumsdaine bought 10,000 shares of the stock in a transaction dated Friday, June 5th. The stock was bought at an average cost of $8.81 per share, with a total value of $88,100.00. Following the completion of the acquisition, the chief financial officer owned 329,183 shares of the company’s stock, valued at $2,900,102.23. This trade represents a 3.13% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.90% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Ardent Health by 103.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock worth $194,000 after buying an additional 7,182 shares during the period. Goldman Sachs Group Inc. lifted its stake in Ardent Health by 1,684.9% in the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after buying an additional 724,841 shares during the last quarter. Jane Street Group LLC boosted its holdings in shares of Ardent Health by 235.1% during the first quarter. Jane Street Group LLC now owns 57,468 shares of the company’s stock valued at $790,000 after acquiring an additional 40,318 shares during the period. Acadian Asset Management LLC boosted its holdings in shares of Ardent Health by 574.9% during the first quarter. Acadian Asset Management LLC now owns 40,238 shares of the company’s stock valued at $550,000 after acquiring an additional 34,276 shares during the period. Finally, Geode Capital Management LLC grew its position in shares of Ardent Health by 0.6% during the second quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock worth $3,918,000 after acquiring an additional 1,769 shares during the last quarter.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.